WGc0201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WGc0201, covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection [Phase 1]